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Genetic-Environmental Interactions in
Relation to Low Dose Studies:
A Possible Model from Breast Cancer
By Nicholas L. Petrakis*
The identification of genetically susceptible individuals may permit the determination of
genetic and environmental interactions which result in disease. This paper presents some recent
findings on possible genetic-environmental interactions in breast disease as determined by a
"nature-nurture" model employing epidemiological risk factors and cytologic studies of breast
secretions obtained by nipple aspiration. The findings indicate that severe changes in the
cytologic characteristics of the fluid are associated with a positive family history of breast
cancer and clinical fibrocystic disease. These findings were interpreted as supporting the
hypothesis that women with such a family history may have increased susceptibility to
environmental factors. This model may have utility in other environmental epidemiologic
studies.
An important objective of research in environ-
mental epidemiology is to detect those individuals
who, because of their genetic susceptibility to
environmental factors, are prone to develop ill-
ness. Identifying genetic susceptibility may permit
us to determine how environmental factors inter-
act to produce disease and so lead to the develop-
ment of preventive measures.
Genetic-environmental interactions have been
recognized since the early days of genetics. But
not until the recent development of biochemical
genetics and pharmacogenetics has the potential
influence of differential genetic susceptibility in
host response to varying environments been ap-
preciated. The studies indicate that genetically
determined differences in an individual's constitu-
tion may determine how that person will respond
to environmental chemical agents (1).
More recently, it has been found that, in addition
to ionizing radiations, many chemical agents can
damage DNA, alter its biochemical and physiologic
expression and, in some individuals, lead to ill
health and disease (2). The problem is compounded
*Department of Epidemiology and International Health,
University of California, School of Medicine, San Francisco,
California 94143.
December 1981
because most known environmental agent factors
implicated in the major noninfectious diseases are
weak; the diseases allegedly caused by them in-
volve low dose rates as well as the interaction of
multiple factors.
An early example of genetic-environmental in-
teraction related to disease is differential suscepti-
bility to malaria of children who have or do not
have the sickle trait (3). Other examples include
G6PD deficiency-an X-linked trait-and suscep-
tibility to primaquin, and, as found later, differing
susceptibility to a host of chemical substances (4).
The abnormal response of erythrocytes in G6PD
deficiency to numerous drugs stimulated the de-
velopment of the field of pharmacogenetics (5). A
variety of genetic systems have been identified
through the use of and reaction to medications. A
recent example, and a model for studies in the
metabolism of carcinogens, revealed genetic dif-
ferences among individuals in metabolizing the
antituberculosis drug isoniazid by liver acetyl-
transferase. Subsequent studies indicated consid-
erable genetic-racial variation in the inactivation of
the drug.
Through the pioneering work of the Millers and
many subsequent workers, it is now evident that
most procarcinogens are metabolically activated
97by cellular enzymes to the ultimate chemical carci-
nogenic form (6). The process involves the micro-
somal cytochrome P448-450 enzyme systems which
detoxify and metabolize many toxic substances
before their elimination. The liver is the major site
of these enzymes, but all tissues, including the
breast, show some enzymatic activity. Experi-
ments in mice indicate that the metabolism of
polycyclic hydrocarbons is under genetic control
and that different mouse strains have differing
metabolism and susceptibility to carcinogenesis for
these substances (7). Kellerman, Shaw and others
(8, 9) reported that exposure ofhuman lymphocyte
cultures to benzpyrene led to the induction of
BP-hydroxylase enzyme and that lymphocytes from
lung cancer patients could be induced to higher
enzyme levels than lymphocytes from controls. It
was suggested that the mechanism might underlie
the differential susceptibility to lung cancer in
response to cigarette smoke, known to contain
benzpyrene and related polycyclic hydrocarbons.
The earlier beliefthat inducibility ofBP-hydroxylase
was inherited as a simple Mendelian trait giving
three distinct genotypes was not confirmed by
other researchers. Instead, it appears that there is
continuous variation from low to high levels of
BP-hydroxylase inducibility among members of
the population, indicating a more complex genetic
variation in BP-hydroxylase inducibility.
In response to the DNA-damaging action of
environmental chemical agents, nature has evolved
enzyme systems for DNA repair. The repair
mechanisms came to light after Cleaver reported
that skin cells from xeroderma pigmentosum, a
genetically dominant disease leading to skin can-
cer, were unable to repair their DNA after dam-
age by ultraviolet light, x-rays and carcinogenic
chemicals (10). Similar defective DNA-repair sys-
tems were demonstrated in other rare genetic
conditions such as ataxia telangiectasia and in
Fanconi's anemia (11). However, in ordinary can-
cers, the genetic predisposition probably resides in
the differing metabolic rates and the activation of
mutagens to carcinogens that tend to overwhelm
the normal DNA-repair mechanisms.
Recent work in our laboratory, which deals with
the genetic epidemiology of breast cancer, indi-
cates possible genetic-environmental interaction.
That breast cancer in some women had a familial
component has been known for many years (12).
Women with a first degree relative (mother, sis-
ter', daughter) with breast cancer have a two-to
threefold increased risk of also developing breast
cancer. The risk is increased significantly if the
cancer in the relative occurred premenopausally
and was bilateral. Very recently, King, Elston,
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Go, Lynch and Petrakis (13) reported evidence for
the existence ofan allele that increases susceptibil-
ity to human breast cancer in certain very high
risk families. The susceptibility allele appears to
be linked to the polymorphic glutamate-pyruvate
transaminase (GPT) locus on chromosome 10. How-
ever, because the GPT genetic marker is not
associated with risk ofbreast cancer in the general
population, it cannot be used as a screening device
for susceptibility to breast cancer. Nevertheless,
the finding strengthens the likelihood that genetic
susceptibility to breast cancer exists and that it
might be detected by other techniques. This would
enable the investigation ofgenetic interaction with
"environmental" factors. The present study pres-
ents some new evidence from our research on
nipple aspirates of breast fluid which may be
indicative of potential genetic-environmental in-
teractions involving breast epithelium.
Over the past seven years our staff has been
investigating the genetic epidemiology and patho-
physiology of breast cancer and benign breast
disease, with emphasis on breast secretory activi-
ty. We have developed a working hypothesis that
emphasizes breast epithelial metabolic and secre-
tory activity as a key factor in the pathogenesis of
breast disease (14). The breast epithelium contains
the enzymatic mechanism for metabolizing poten-
tially toxic and carcinogenic substances transported
in the blood. These genetically conditioned meta-
bolic and physiologic activities may, in the appro-
priate environmental circumstances, lead to epi-
thelial damage and ultimately to breast disease.
Before discussing our most recent cytologic re-
sults, some of our basic findings on nipple aspi-
rates of breast fluids will be presented.
The women in this study had voluntarily come to
be examined at the University ofCalifornia Hopsitals
and Clinics, the Breast Screening Center of North-
ern California, and other community health and
screening centers. All women completed a ques-
tionnaire on their demographic, clinical, marital,
reproductive and other characteristics. A specially
trained nurse or a physician examined their breasts.
On both breasts, nipple aspiration was attempted,
employing the technique described previously (15).
A woman was defined as "secretor" if a drop or
more of fluid appeared at the nipple surface after
application of the breast pump with the syringe
retracted to 10 cc and held up to 15 sec. It is
necessary to exert this degree of negative pres-
sure to force breast fluid through the closed nipple
ducts of most nonlactating adult women. We
believe that applications of lower negative pres-
sures, as reported by others, may not provide an
accurate estimate ofbreast secretory activity. Our
Environmental Health Perspectivesfindings will be presented in terms of (a) breast
secretor status and breast cancer risk factors, (b)
secretion of mutagenic substances and (c) use of
breast fluid cytology to evaluate potential genetic-
environmental interactions with breast cancer risk
factors. For the purposes of this presentation,
breast cancer risk factors are considered as being
predominantly environmental in origin and of "low
dose" in their magnitude.
Breast Secretory Activity and
Breast Cancer Risk Factors
We have investigated the proportion of secretors
associated with the major breast cancer risk fac-
tors. Earlier, we reported that "secretion" was
associated with race, age, menopausal status and
the genetically determined cerumen type (15).
More extensive data from over 5,000 women
support these findings and add new evidence. The
findings on secretory activity are in accord with
the endocrine-dependent nature ofthe breast gland;
and we have found additional evidence for an
association of genetically determined cerumen type
and breast fluid secretion, evidence that mutagenic
substances are secreted into the breast ducts, and
that severe cytologic alterations are present in
breast fluid epithelial cells from a high proportion
of women with a first degree family history of
breast cancer which, in turn, is associated with
breast cancer risk factors.
In general, our studies of the occurrence of
secretion by nipple aspiration appear to be in
agreement with selected breast cancer risk fac-
tors, reflecting the degree of ovarian activity and
its changes in response to reproductive history.
These findings are not unexpected, as most known
breast cancer risk factors are strongly associated
with endocrine and reproductive characteristics.
Biochemical Aspects of Breast
Fluid Secretion
Based on our studies, we have proposed that the
endocrine and genetically dependent secretory ac-
tivity of the breast can provide a physiologic
mechanism whereby initiating and promoting chem-
ical carcinogens can reach the breast alveolar-
ductal system. In support of this hypothesis, we
have found that a variety of exogenously derived
substances are secreted by the nonlactating breast
(14). We hypothesize that in genetically predis-
posed and metabolically activated breast epithe-
lium the uptake and secretion of mutagenic sub-
stances conceivably could lead to the initiation,
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accumulation and promotion of mutant epithelial
cells and eventually to the emergence of cancer
cells or to benign-type breast conditions.
We have found evidence that putative muta-
genic substances do reach the breast fluid (16). In
612 breast fluids specimens, tested with the Ames
Salmonella TA 1538 strain with S-9 homogenate,
we found 31 (7%) to give a positive test. The
nature of the substance or substances giving the
positive test is unknown. It is possible that chemi-
cal substances like hair dyes, food components,
chemicals used in the workplace, substances in
tobacco smoke, lipid peroxides, etc., may be re-
sponsible for positive Ames tests. It is of interest
also that intravenous administration of thiotepa to
a patient was followed, within a few minutes, by a
positive Ames test. Moreover, two women with
strongly positive Ames tests were undermedication
with a chlorinated phenothiozine tranquilizer
(Eskatrol) shown to cause positive Ames tests. We
have not been able to find any association between
Ames positivity and the reproductive breast can-
cer risk factors.
A fundamental question can be asked: "Do these
exogenous substances do anything of clinical or
biological significance to the breast epithelium?"
The answers may be provided by newer and more
refined techniques of cell cultures of breast fluids.
However, some recent findings suggest it may be
possible to define, more precisely, by epidemiologic
and cytologic methods, high and low risk groups of
women.
Cytologic Studies of Breast
Fluid: Associations with Breast
Cancer Risk Factors
Breast fluid contains epithelial cells that are
desquamated from the epithelial lining, the alveoli
and the ducts. Nipple aspirate cytology, studied
by Papanicolaou (17), Sartorius (18), King (19, 20),
Buehring (21) and others, indicate that cytologic
atypical hyperplasia and dysplasia are likely to
reflect precursor glandular lesions and occur in
association with breast cancer. Table 1 summa-
rizes our findings in cytology from over 3800
women who underwent nipple aspiration. Ofbreast
cancer patients, 64% had atypical hyperplasia; of
those with biopsied benign breast disease 31% had
atypical cells, and of clinically normal women only
15% had atypical cells, indicating a very high
relative risk of atypical cytology in women with
breast cancer, a somewhat lower risk in benign
disease, and a smaller but still substantial propor-
tion of risk in apparently normal women. Howev-
99Table 1. Atypical cytology in nipple aspirates of breast fluid by clinical status.
Atypical
Clinical status Number total S Relative risk Confidence interval
Breast cancer 42/65 64.6 9.9 (6.9-14.1)a
Fibrocystic disease (biopsy) 77/242 31.8 2.5 (2.0-3.2)a
No clinical disease 552/3541 15.6 1.0
ap < 0.0001.
er, it should be emphasized that we have not found
nipple aspiration cytology to be useful as a screen-
ing device for breast cancer because of the rarity
of cancer cells in breast fluid even in the presence
of cancer, and the very high proportion of false
positive tests that would be encountered in a
screening program. In an overall tabulation by
age, the proportion of cytologic atypia appears to
increase from about 15% between ages 20 and 40,
up to 23% by age 50 and then to decline.
Because of the strong association between atyp-
ical hyperplasia and breast cancer, we investigated
possible associations of atypical hyperplasia and
the major breast cancer risk factors (Table 2).
Only first-degree family history of breast cancer
(FH+), clinical fibrocystic disease (FCD+) and
estrogen use showed a significant association with
cytologic atypical hyperplasia. These observations
led us to consider that nipple aspirate cytology
might provide a way to investigate the association
of genetic predisposition and atypical hyperplasia
of breast epithelium and, presumably, susceptibil-
ity to breast cancer.
Based on these findings, we decided to examine
the relationship of atypical epithelial hyperplasia
and the various risk factors for breast cancer in
terms of potential genetic-environmental interac-
tions.
The model depicted in Figure 1 shows the
phenotype (atypical epithelial hyperplasia) result-
ing from a combination of genetic susceptibility (a
first-degree family history of breast cancer) and
environmental factors (the other breast cancer risk
factors-primarily related to the endocrine and
reproductive systems) and their interaction. In
this model based upon the classic "phenotype =
genetics + environment," a first-degree family
history of breast cancer is considered as the
"genetic susceptibility factor" which may interact
with a variety of "environmental" factors. The
breast cancer risk factors shown in Figure 1 are
considered predominantly environmentally condi-
tioned. Studies by others (22-24) have attempted
to examine the effect of multiple risk factors on
breast cancer risk, but have not employed the genetic-
environmental interaction concept presented here.
Women with a first-degree family history of
breast cancer are likely to have an increased risk
of developing breast cancer and are more prone if
they are in the premenopausal age group. As a
group, such women would be more likely to
possess a gene or genes which might increase the
susceptibility and responsiveness of their breast
epithelium to "environmental factors." Genes could
influence susceptibility to atypical hyperplasia and
to breast cancer through their regulation of hor-
monal stimuli, or by controlling the response of
breast epithelial cells to these stimuli and by
influencing the metabolism of extrinsic chemical
substances. We believe that these types of effects
might be detectable as atypical epithelial hyper-
plasia in breast fluid.
The proportion of atypical cells and the relative
tion," where the "genetic" susceptibility factors in
Table 2. Atypical cytology in nipple aspirates: association with breast cancer risk factors in women 50 years of age.a
At higher risk At lower risk Confidence
Risk factor Atypical/total % Atypical/total % Odds ratio interval
Age menarche £ 12 vs. a 14 113/696 16.2 23/141 16.3 .99 0.66-1.49
Nulliparous vs. parous 44/297 14.8 203/1195 17.0 0.79 0.58-1.06
1st pregnancy a 31 vs. £ 20 13/76 17.1 37/305 12.1 1.49 0.84-2.65
Income a $15,000 vs. £ 14,000/yr. 33/176 18.8 48/274 17.5 1.08 0.72-1.64
Oral contraceptive vs. no oral contraceptive 33/820 16.5 214/1336 16.0 1.05 0.75-1.48
Estrogen vs. no estrogen 32/151 21.1 231/1449 15.9 1.42 1.03-2.00
10 family history positive vs. negative 39/177 22.0 217/1392 15.6 1.53 1.11-2.11
Clinical FCD positive vs. FCD negative 79/406 19.4 182/1163 15.6 1.30 1.02-1.66
aNot age-adjusted.
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Secreted mutagens and chemical substances
Phenotype Genetic Susceptibility that act as initiators and promotors
Fibrocystic disease (dietary)
Atypical = 10 Family history of + Age at menarche (dietary)
epithelial breast cancer Parity (behavioral and dietary)
hyperplasia (50% shared genes) Age at first pregnancy (behavioral and social)
Surgical menopause (medical, behavioral)
Menopausal estrogen (medical, behavioral)
FIGURE 1. Possible genetic-environmental interactions leading to atypical breast fluid cytology. P = G + E + GE.
risk and confidence intervals were calculated for
each combination of family history and one risk
factor, using the women who are negative for both
factors as the comparison group. Mantel-Haenszel
summary stratification analyses were then made
on the four groups. It is of interest to note that
Tokuhata conducted a similar epidemiologic analy-
sis of lung cancer mortality among subjects who
had and those who did not have a family history of
lung cancer and cigarette smoking (25). The data
presented here will deal with women
- 50 years.
The proportion of women with atypical cytology
stratified by categories of FH- and FH + and
FCD- and FCD + are shown in Table 3. The
proportion of women with atypical hyperplasia
increases progressively from 14.5 to 25% and so
does their relative risk. The increase would
demonstrate an additive effect of family history
and fibrocystic disease on the risk of atypical
hyperplasia, with highest risk when both factors
are positive.
The data presented above were not age-adjusted.
In another article, we present age-adjusted analy-
ses that support the conclusion of interactions
similar to those in Tables 2 and 3 (26).
Discussion
Our findings relating breast fluid cytology and
breast cancer risk factors appear to offer support
for the hypothesis that women with a first-degree
family history ofbreast cancer may have increased
susceptibility to "environmental factors" as indi-
cated by the increased proportion of atypical
hyperplastic cells and an increased relative risk of
atypia compared to women without a family histo-
ry. The findings are also in agreement with nu-
merous reports of the association of epithelial
histologic abnormalities in "premalignant" breast
cancer (14).
Women with both a positive first-degree family
history of breast cancer and fibrocystic disease
were found to have a significantly greater relative
risk of atypical hyperplasia than women with only
one of these factors. The presence of both factors
was associated with an even higher relative risk of
cytologic atypical hyperplasia in parous women, in
women whose age at first pregnancy was under 20
years and in women using menopausal estrogens.
It must be emphasized that these data are from
work still in progress. As noted earlier, the breast
epithelia may be exposed through the breast
secretorymechanism to exogenouslyderived chemi-
cals, including mutagenic and carcinogenic sub-
stances. These substances might exert greater
effects on "genetically susceptible" epithelia of
women with both a first degree family history of
breast cancer and fibrocystic disease. We suggest
that our findings on breast cytology represent an
example of genetic and environmental "interac-
Table 3. Proportion atypical cytology in nipple aspirates: association withfamily history (FH) and/orfibrocystic disease (FCD)
for women
- 50 years ofage.a,b
Atypical
Family history Fibrocystic disease Number/total % Odds ratio Confidence interval
FH- FCD- 151/1038 14.5 1.00
FH- FCD+ 66/354 15.8 1.35 1.03-1.76
FH+ FCD- 26/125 20.8 1.54 1.05-2.27
FH+ FCD+ 13/52 25.0 1.96 1.15-3.46
aMantel-Haenszel relative risk 1.47 (1.20-1.80).
bNot age-adjusted.
December 1981 101women with a first degree family history of breast
cancer may interact with "environmental factors"
which potentially may lead to breast disease. The
findings lead us to propose that the breast epithe-
Hum ofwomen who have both positive first-degree
family history ofbreast cancer and clinical fibrocystic
disease may be more prone to abnormal differenti-
ation than the breast epithelium ofwomen without
these risk factors. The biochemical mechanisms
that might underlie these processes are as yet
unknown. The use offirst-degree family history of
breast cancer as "genetic" susceptibility is clearly
not completely warranted. Probablythe less specific
term "host" might have been more correct. How-
ever, the positive and consistent findings in com-
binations ofrisk factors with FH+ compared with
FH- women suggests that our approach may be a
productive way to attempt to more precisely focus
on possible genetic susceptibility factors in breast
cancer epidemiology.
Future studies, stratified according to family
history of breast cancer and risk factors as pre-
sented here, would offer an opportunity for epi-
demiological and laboratory investigations of po-
tential genetic-environmental interactions of en-
vironmental carcinogens, dietary and other factors
on the production and reversal of atypical hyper-
plasia of breast epithelium. Control of atypical
hyperplasia might lead to means of preventing
breast disease and breast cancer.
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